The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
Open accessAbstract
The rapidly spreading outbreak of COVID-19 disease is caused by the SARS-CoV-2 virus, first reported in December 2019 in Wuhan, China. As of June 17, 2020, this virus has infected over 8.2 million people but ranges in symptom severity, making it difficult to assess its overall infection rate. There is a need for rapid and accurate diagnostics to better monitor and prevent the spread of COVID-19. In this review, we present and evaluate two main types of diagnostics with FDA-EUA status for COVID-19: nucleic acid testing for detection of SARS-CoV-2 RNA, and serological assays for detection of SARS-CoV-2 specific IgG and IgM patient antibodies, along with the necessary sample preparation for accurate diagnoses. In particular, we cover and compare tests such as the CDC 2019-nCoV RT-PCR Diagnostic Panel, Cellex's qSARS-CoV-2 IgG/IgM Rapid Test, and point-of-care tests such as Abbott's ID NOW COVID-19 Test. Antibody testing is especially important in understanding the prevalence of the virus in the community and to identify those who have gained immunity. We conclude by highlighting the future of COVID-19 diagnostics, which include the need for quantitative testing and the development of emerging biosensors as point-of-care tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Engvall, E., & Perlmann, P. (1972) · PubMed · Cited by 3,107
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Seo, G., Lee, G., Kim, M. J., Baek, S.-H., Choi, M., Ku, K. B., Lee, C.-S., Jun, S., Park, D., Kim, H. G., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02823 · Cited by 1,837
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745 · cited 1×
“In current vaccine efficacy trials, it takes a few months after an individual has been given the vaccine to determine and validate if he or she is mounting the appropriate immune response through antibody production (Plotkin, 2010).”
BackgroundOkba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa310 · Cited by 1,587
Interpreting Diagnostic Tests for SARS-CoV-2
Sethuraman, N., Jeremiah, S. S., & Ryo, A. (2020) · JAMA · doi:10.1001/jama.2020.8259 · Cited by 1,494
Bhalla, N., Jolly, P., Formisano, N., & Estrela, P. (2016) · Essays in Biochemistry · doi:10.1042/ebc20150001 · Cited by 1,312
Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management
Li, Y., & Xia, L. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22954 · Cited by 1,294
Koczula, K. M., & Gallotta, A. (2016) · Essays in Biochemistry · doi:10.1042/ebc20150012 · Cited by 1,147
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L.-A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 903
Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868
Yang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., et al. (2020) · doi:10.1101/2020.02.11.20021493 · Cited by 836 · cited 2×
“When possible, the CDC recommends healthcare providers also take lower respiratory specimens, which can be valuable samples for diagnosing COVID-19 in severe cases (Yang et al., 2020).”
BackgroundCOVID-19 antibody seroprevalence in santa clara county, california
Bendavid, E., Mulaney, B., Sood, N., Shah, S., Bromley-Dulfano, R., Lai, C., Weissberg, Z., Saavedra-Walker, R., Tedrow, J., Bogan, A., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab010 · Cited by 669
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
Cheng, M. P., Papenburg, J., Desjardins, M., Kanjilal, S., Quach, C., Libman, M., Dittrich, S., & Yansouni, C. P. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1301 · Cited by 593
Wang, Y., Kang, H., Liu, X., & Tong, Z. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25721 · Cited by 454
Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
Sweeney, T. E., Braviak, L., Tato, C. M., & Khatri, P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00048-5 · Cited by 445
Duration of Antibody Responses after Severe Acute Respiratory Syndrome
Wu, L.-P., Wang, N.-C., Chang, Y.-H., Tian, X.-Y., Na, D.-Y., Zhang, L.-Y., Zheng, L., Lan, T., Wang, L.-F., & Liang, G.-D. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1310.070576 · Cited by 426
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al. (2020) · doi:10.1101/2020.03.13.990226 · Cited by 419
Self-citationThe Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020) · Journal of Virology · doi:10.1128/jvi.00647-20 · Cited by 410
Layqah, L. A., & Eissa, S. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3345-5 · Cited by 380
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Payne, D. C., Iblan, I., Rha, B., Alqasrawi, S., Haddadin, A., Al Nsour, M., Alsanouri, T., Ali, S. S., Harcourt, J., Miao, C., et al. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2210.160706 · Cited by 201
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
Loeffelholz, M. J., Alland, D., Butler-Wu, S. M., Pandey, U., Perno, C. F., Nava, A., Carroll, K. C., Mostafa, H., Davies, E., McEwan, A., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00926-20 · Cited by 180
Andres-Terre, M., McGuire, H. M., Pouliot, Y., Bongen, E., Sweeney, T. E., Tato, C. M., & Khatri, P. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.003 · Cited by 175
Wolters, F., van de Bovenkamp, J. H. B., van den Bosch, B., van den Brink, S., Broeders, M. M. C., Chung, N. H., Favié, B., Goderski, G., Kuijpers, J., Overdevest, I. T. M. A., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104426 · Cited by 148
Zhai, Y., Franco, L. M., Atmar, R. L., Quarles, J. M., Arden, N. H., Bucasas, K. L., Wells, J. M., Niño, D., Wang, X., Zapata, G. E., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004869 · Cited by 146
Lin, C., Xiang, J., Yan, M., Li, H., Huang, S., & Shen, C. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0187 · Cited by 146
Portable GMR Handheld Platform for the Detection of Influenza A Virus
Wu, K., Klein, T., Krishna, V. D., Su, D., Perez, A. M., & Wang, J. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00432 · Cited by 144
Precautions Are Needed for COVID-19 Patients with Coinfection of Common Respiratory PathogensPreprint
Xing, Q., Li, G., Xing, Y., Chen, T., Li, W., Ni, W., Deng, K., Gao, R., Chen, C.-Z., Gao, Y., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.02.29.20027698 · Cited by 118
Bradley, T., Ferrari, G., Haynes, B. F., Margolis, D. M., & Browne, E. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.020 · Cited by 115
Lee, J. S., Goldstein, J. M., Moon, J. L., Herzegh, O., Bagarozzi, D. A., Oberste, M. S., Hughes, H., Bedi, K., Gerard, D., Cameron, B., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0260487 · Cited by 110
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review
Cheng, M. P., Papenburg, J., Desjardins, M., Kanjilal, S., Quach, C., Libman, M., Dittrich, S., & Yansouni, C. P. (2020) · eScholarship@McGill (McGill) · Cited by 87
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay
Bordi, L., Piralla, A., Lalle, E., Giardina, F., Colavita, F., Tallarita, M., Sberna, G., Novazzi, F., Meschi, S., Castilletti, C., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104416 · Cited by 75
Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections
Wang, P. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.113919 · Cited by 70
Antibody detection of SARS-CoV spike and nucleocapsid protein
Chang, M.-S., Lu, Y., Ho, S.-T., Wu, C.-C., Wei, T., Chen, C.-J., Hsu, Y.-T., Chu, P.-C., Chen, C.-H., Chu, J.-M., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.195 · Cited by 69
Nelson, P. P., Rath, B. A., Fragkou, P. C., Antalis, E., Tsiodras, S., & Skevaki, C. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00181 · Cited by 65
Immunosignatures can predict vaccine efficacy
Legutki, J. B., & Johnston, S. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309390110 · Cited by 53
2885. A Host Transcriptional Signature for Accurate Diagnosis of Candidemia in the Hospital Setting
Steinbrink, J. M., Hua, K., Myers, R. A., Johnson, M. D., Seidelman, J., Tsalik, E. L., Tsalik, E. L., Alexander, B. D., & McClain, M. T. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz359.163 · Cited by 2
Cited by
Advancing COVID-19 diagnosis with privacy-preserving collaboration in artificial intelligence
Bai, X., Wang, H., Ma, L., Xu, Y., Gan, J., Fan, Z., Yang, F., Ma, K., Yang, J., Bai, S., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00421-z · Cited by 75
Metadata
- Authors
- Ravi, N., Cortade, D. L., Ng, E., & Wang, S. X.
- Venue
- Biosensors and Bioelectronics
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 165
- Pages
- 112454
- ISSN
- 0956-5663 (ISSN-L)
- OpenAlex
- W3042554514
- Cited by
- 371
- References
- 46
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.